Cancer Treatment Reviews
Volume 30, Issue 7 , Pages 599-607 , November 2004

Partial breast irradiation: revolution or evolution?

  • J.M. Hannoun-Levi

      Affiliations

    • Department of Radiation Oncology, Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France
    • Corresponding Author InformationCorresponding author. Present address: Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA. Tel.: +1-215-214-1479; fax: +1-215-728-2868
    • ,
  • J.J. Mazeron

      Affiliations

    • Department of Radiation Oncology, Hopital de la Pitie Salepetriere, 47 bd Hôpital 75013 Paris, France
    • ,
  • H. Marsiglia

      Affiliations

    • Department of Radiation Oncology, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France
    • Brachytherapy Unit, Radiation Oncology Department, European Institute of Oncology, Milan, Italy
    • ,
  • J.P. Gerard

      Affiliations

    • Department of Radiation Oncology, Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France

References 

  1. Veronesi U, Banfi A, Saccozzi R, et al. Conservative treatment of breast cancer. A trial in progress at the Cancer Institute of Milan. Cancer. 1977;39:2822–2826
  2. Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer. 1977;39:2827–2839
  3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N. Engl. J. Med. 2002;347:1227–1232
  4. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 2002;347:1233–1241
  5. Cionini L, Pacini P, Marzano S, et al. Exclusive brachytherapy after conservative surgery in cancer of the breast. Lyon. Chir. 1993;89:128;[abstract]
  6. Fentiman IS, Poole C, Tong D, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur. J. Cancer. 1991;27:447–450
  7. Fentiman IS, Poole C, Tong D, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur. J. Cancer. 1996;32A:608–611
  8. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am. J. Surg. 2000;180:299–304
  9. Vicini F, Kini VR, Chen P, et al. Irradiation of the tumour bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J. Surg. Oncol. 1999;70:33–40
  10. Perera F, Engel J, Holliday R, et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J. Surg. Oncol. 1997;65:263–267
  11. Kuske R, Bolton J, Wilenzick R, et al. Brachytherapy as the sole method of breast irradiation in Tis, Tl, T2, NO-1 breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1994;30(suppl 1):S245;[abstract]
  12. Polgar C, Major T, Somogyi A, et al. Brachytherapy of the tumour bed after breast conserving surgery: new radiotherapeutic option in the management of early breast cancer. Orv. Hetil. 1999;140:1461–1466
  13. Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J. Clin. Oncol. 2001;19:1993–2001
  14. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J. Natl. Cancer Inst. 2003;95:1205–1210
  15. Jewell WR, Krishnan L, Reddy EK, et al. Intraoperative implantation radiation therapy plus lumpectomy for carcinoma of the breast. Arch. Surg. 1987;122:687–690
  16. Krishnan L, Jewell WR, Tawfik OW, et al. Breast conservation therapy with tumour bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7:91–96
  17. Wazer DE, Berle L, Graham R, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002;53:889–897
  18. Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumour bed after conservative surgery for Tl breast cancer: five-year results of a phase I–II study and initial findings of a randomized phase III trial. J. Surg. Oncol. 2002;80:21–28
  19. Ribeiro GG, Magee B, Swindell R, et al. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin. Oncol. (R. Coll. Radiol.). 1993;5:278–283
  20. Formenti SC, Rosenstein B, Skinner KA, et al. Tl stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumour bed in selected postmenopausal breast cancer patients–pilot feasibility study. Radiology. 2002;222:171–178
  21. Veronesi U, Orecchia R, Luini A, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur. J. Cancer. 2001;37:2178–2183
  22. Dubois JB, Hay M, Gely S, et al. IORT in breast carcinomas. Front Radiat. Ther. Oncol. 1997;31:131–137
  23. Vaidya JS, Baum M, Tobias JS, et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann. Oncol. 2001;12:1075–1080
  24. Nag S. The evolving role of brachytherapy in breast cancer. Am. J. Clin. Oncol. 1995;18:353–357
  25. White JR, Wilson JF. Brachytherapy and breast cancer. Semin. Surg. Oncol. 1997;13:190–195
  26. Deore SM, Sarin R, Dinshaw KA, et al. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases. Int. J. Radiat. Oncol. Biol. Phys. 1993;26:601–606
  27. Wazer DE, Lowther D, Boyle T, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:107–111
  28. Boyages J, Bilous M, Barraclough B, et al. Fat necrosis of the breast following lumpectomy and radiation therapy for early breast cancer. Radiother. Oncol. 1988;13:69–74
  29. Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int. J. Radiat. Oncol. Biol. Phys. 2002;52:1132–1139
  30. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 2003;55:289–293
  31. Dutreix J, Cosset JM, Girinsky T. Biological equivalency of high single doses used in intraoperative irradiation. Bull. Cancer Radiother. 1990;77:125–134
  32. Hannoun-Levi JM, Courdi A, Marsiglia H, et al. Breast cancer in elderly women: is partial breast irradiation a good alternative. Breast Cancer Res. Treat. 2003;81:243–251
  33. Buchholz TA, Austin-Seymour MM, Moe RE, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1993;26:23–35
  34. Leonard CE, Wood ME, Zhen B, et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control. J. Clin. Oncol. 1995;13:2906–2915
  35. Hebert-Croteau N, Freeman CR, Latreille J, et al. Delay in adjuvant radiation treatment and outcomes of breast cancer – a review. Breast Cancer Res. Treat. 2002;74:77–94
  36. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1995;333:1456–1461
  37. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J. Natl. Cancer Inst. 1996;88:1659–1664
  38. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996;348:708–713
  39. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J. Clin. Oncol. 1999;17:2326–2333
  40. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann. Oncol. 2001;12:997–1003
  41. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group. Lancet 2000;355:1757–70
  42. Remouchamps VM, Vicini FA, Sharpe MB, et al. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2003;55:392–406
  43. Remouchamps VM, Letts N, Yan D, et al. Three-dimensional evaluation of intra- and interfraction immobilization of lung and chest wall using active breathing control: a reproducibility study with breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 2003;57:968–978
  44. Burkhardt JH, Litwin MS, Rose CM, et al. Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer. J. Clin. Oncol. 2002;20:2869–2875
  45. Brandeis J, Pashos CL, Henning JM, et al. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer. 2000;89:1792–1799
  46. Barlow WE, Taplin SH, Yoshida CK, et al. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J. Natl. Cancer Inst. 2001;93:447–455
  47. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer. 1986;57:1717–1724
  48. Fowble B, Solin LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int. J. Radial. Oncol. Biol. Phys. 1990;19:833–842
  49. Veronesi U, Salvadori B, Luini A, et al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann. Surg. 1990;211:250–259
  50. Liljegren G, Holmberg L, Adami HO, et al. Sector resection with or without II postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J. Natl. Cancer Inst. 1994;86:717–722
  51. Vaidya JS, Vyas JJ, Chinoy RF, et al. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br. J. Cancer. 1996;74:820–824
  52. Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumour relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:1281–1289
  53. Wallner P, Arthur D, Bartelink H, et al. Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8–10, 2002. J. Natl. Cancer Inst. 2004;96:175–184
  54. Freedman GM, Hanlon AL, Anderson PR. Pattern of local recurrence after conservative surgery and whole-breast radiation: implications for partial breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2003;57(Suppl. 2):S171
  55. Gruenberger T, Gorlitzer M, Soliman T, et al. It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res. Treat. 1998;50:37–46
  56. Benhaim DI, Lopchinsky R, Tartter PI. Lumpectomy with tamoxifen as primary treatment for elderly women with early-stage breast cancer. Am. J. Surg. 2000;180:162–166
  57. Diab SG, Elledge RM, Clark GM. Tumour characteristics and clinical outcome of elderly women with breast cancer. J. Natl. Cancer Inst. 2000;92:550–556
  58. Solin LJ, Schultz DJ, Fowble BL. Ten-year results of the treatment of early-stage breast carcinoma in elderly women using breast-conserving surgery and definitive breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1995;33:45–51
  59. Vlastos G, Mirza NQ, Meric F, et al. Breast conservation therapy as a treatment option for the elderly. The M.D. Anderson experience. Cancer. 2001;92:1092–1100
  60. Ballard-Barbash R, Potosky AL, Harlan LC, et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J. Natl. Cancer Inst. 1996;88:716–726
  61. Hebert-Croteau N, Brisson J, Latreille J, et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer. 1999;85:1104–1113
  62. Nattinger AB, Kneusel RT, Hoffmann RG, et al. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J. Natl. Cancer Inst. 2001;93:1344–1346
  63. Cowen D, Houvenaeghel G, Bardou V, et al. Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000;47:305–312
  64. Vicini FA, Kestin L, Huang R, et al. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy. Cancer. 2003;97:910–919
  65. Maulard C, Housset M, Brunei P, et al. Use of perioperative or split-course interstitial brachytherapy techniques for salvage irradiation of isolated local recurrences after conservative management of breast cancer. Am. J. Clin. Oncol. 1995;18:348–352
  66. Polgar C, Sulyok Z, Major T, et al. Reexcision and perioperative brachytherapy in the treatment of local relapse after breast conservation: a possible alternative to mastectomy. Magy. Seb. 2000;53:120–123
  67. Resell A, Fellner C, Mock U, et al. Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy a second chance to preserve the breast. Radiology. 2002;225:713–718
  68. Guix B, Henriquez I, Tello JI, et al. Second conservative treatment as salvage treatment for local recurrences of the breast. 12-y results from a pilot study. Radiother. Oncol. 2003;66(Suppl. 1):S15;[abstact]
  69. Hannoun-Levi JM, Houvenaeghel G, Ellis S, et al. Partial breast irradiation as second conservative treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys [in press]
  70. Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J. Clin. Oncol. 1991;9:1059–1070
  71. Ganz PA, Schag AC, Lee JJ, et al. Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery. Cancer. 1992;69:1729–1738
  72. Schover LR. Sexuality and body image in younger women with breast cancer. J. Natl. Cancer Inst. Monogr. 1994;16:177–182
  73. Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J. Natl. Cancer Inst. 2004;96:376–387

PII: S0305-7372(04)00118-5

doi: 10.1016/j.ctrv.2004.06.009

Cancer Treatment Reviews
Volume 30, Issue 7 , Pages 599-607 , November 2004

Article Tools